Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl] piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of pain or residual symptoms in depression relating to sleep and cognition

1-[2-(2,4-dimethylphenylsulfanyl)-phenyl] piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of pain or residual symptoms in depression relating to sleep and cognition

US Patent 8664225 · Granted Mar 4, 2014

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions comprising mixtures of compounds and uses thereof2025
Compositions comprising mixtures of compounds and uses thereof2023
Therapeutic uses of compounds having combined sert, 5-HT3 and 5-HT1a activity2023
Therapeutic uses of compounds having combined SERT, 5-HT3 and 5-HT1A activity2017
Clonidine compounds in a biodegradable matrix2016
Crystalline forms of 4-[2-(4-methylphenylsulfanyl)-phenyl] piperidine2016
TRPV1 compounds in a biodegradable polymer carrier2015
1-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined 2015
1-[2-(2,4 dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined 2015
1-[2-(2,4 dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined 2015
1-[2-(2,4-dimethylphenylsulfanyl)-phenyl] piperazine as a compound with combined2014
1-[2-(2,4-dimethylphenylsulfanyl)-phenyl] piperazine as a compound with combined2014